Related Experiment Video
Updated: May 22, 2026

07:13
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
Determining the feasibility of objective adherence measurement with blister packaging smart technology
Hein A van Onzenoort1, Cees Neef, Willem W Verberk
1Department of Clinical Pharmacy, Radboud University Nijmegen Medical Centre, the Netherlands. h.vanonzenoort@akf.umcn.nl
Summary
Smart Blister technology shows promise for monitoring medication adherence in real-world settings. Design refinements are needed to address issues with simultaneous tablet removal detection for improved accuracy.
Area of Science:
- * Pharmacoeconomics and Health Services Research
- * Digital Health and Medical Device Technology
Background:
- * Objective measurement of medication adherence is crucial for effective therapy.
- * Microprocessor-driven systems are being developed to track medication removal from packaging.
Purpose of the Study:
- * To report the feasibility of blister-pack smart technology for monitoring medication adherence.
- * To evaluate the Smart Blister device in a clinical practice setting.
Main Methods:
- * A feasibility study involving 115 Dutch patients on valsartan maintenance therapy.
- * 14-day blister packages equipped with the Smart Blister device were used.
- * Data on tablet removal were collected from returned blister cards via scanning.
Main Results:
- * The Smart Blister system effectively recorded patient and blister-card data in most cases.
- * 17% of instances showed simultaneous tablet removal, indicating a need for design improvements.
- * Patients and pharmacies generally accepted the Smart Blister medication cards.
Conclusions:
- * The Smart Blister demonstrates potential for real-world medication adherence monitoring.
- * Further design refinements and performance testing are necessary for optimal functionality.
- * The technology shows promise for enhancing patient counseling and therapy management.
